Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to -3.37%.

  • Biofrontera's Return on Capital Employed fell 122.00% to -3.37% in Q3 2025 from the same period last year, while for Sep 2025 it was -3.37%, marking a year-over-year decrease of 122.00%. This contributed to the annual value of -1.32% for FY2024, which is 26.00% down from last year.
  • As of Q3 2025, Biofrontera's Return on Capital Employed stood at -3.37%, which was down 127.34% from 12.33% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Return on Capital Employed registered a high of 12.33% during Q2 2025, and its lowest value of -3.37% during Q3 2025.
  • Over the past 3 years, Biofrontera's median Return on Capital Employed value was -1.85% (recorded in 2024), while the average stood at -0.33%.
  • Within the past 5 years, the most significant YoY rise in Biofrontera's Return on Capital Employed was 1,371bps (2025), while the steepest drop was 122bps (2025).
  • Quarterly analysis of 5 years shows Biofrontera's Return on Capital Employed stood at -1.23% in 2021, then soared by 65bps to -0.58% in 2022, then crashed by 118bps to -1.75% in 2023, then crashed by 32bps to -2.08% in 2024, then plummeted by 122bps to -3.37% in 2025.
  • Its Return on Capital Employed was -3.37% in Q3 2025, compared to 12.33% in Q2 2025 and -1.94% in Q1 2025.